Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Galletti

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
Frontiers in Immunology|November 25, 2021
Dissecting the Human Response to <i>Staphylococcus aureus</i> Systemic InfectionsRosanna Leuzzi, Margherita Bodini, Isaac P Thomsen, et al.
Journal of Medicinal Chemistry|January 11, 2002
Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studiesGiuseppe Campiani, Stefania Butini, Sandra Gemma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2026
Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 TrialEugene Athan, Richard N Greenberg, David A Baker, et al.
Clinical and Vaccine Immunology : CVI|April 1, 2016
Auto-Assembling Detoxified Staphylococcus aureus Alpha-Hemolysin Mimicking the Wild-Type Cytolytic ToxinLuigi Fiaschi, Benedetta Di Palo, Maria Scarselli, et al.
Plos One|January 27, 2016
One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17AFrancesca Mancini, Elisabetta Monaci, Giuseppe Lofano, et al.
Journal of Clinical Medicine|July 12, 2025
ChatGPT in the Management of Chronic Rhinosinusitis with Nasal Polyps: Promising Support or Digital Illusion? Insights from a Multicenter Observational StudyRiccardo Manzella, Angelo Immordino, Cosimo Galletti, et al.
Infection and Immunity|November 16, 2011
RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodiesCarole Harfouche, Sara Filippini, Claudia Gianfaldoni, et al.
Journal of Medicinal Chemistry|December 30, 2003
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agentsGiuseppe Campiani, Stefania Butini, Caterina Fattorusso, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureusFabio Bagnoli, Maria Rita Fontana, Elisabetta Soldaini, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Frontiers in Immunology|November 25, 2021
Dissecting the Human Response to <i>Staphylococcus aureus</i> Systemic InfectionsRosanna Leuzzi, Margherita Bodini, Isaac P Thomsen, et al.
Journal of Medicinal Chemistry|January 11, 2002
Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studiesGiuseppe Campiani, Stefania Butini, Sandra Gemma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 9, 2026
Safety, Efficacy, and Immunogenicity of a Multivalent Adjuvanted S. aureus Vaccine in Adults with Recent Skin And Soft Tissue Infections: An Observer-blind, Randomized, Placebo-controlled, Multinational Phase 1/2 TrialEugene Athan, Richard N Greenberg, David A Baker, et al.
Clinical and Vaccine Immunology : CVI|April 1, 2016
Auto-Assembling Detoxified Staphylococcus aureus Alpha-Hemolysin Mimicking the Wild-Type Cytolytic ToxinLuigi Fiaschi, Benedetta Di Palo, Maria Scarselli, et al.
Plos One|January 27, 2016
One Dose of Staphylococcus aureus 4C-Staph Vaccine Formulated with a Novel TLR7-Dependent Adjuvant Rapidly Protects Mice through Antibodies, Effector CD4+ T Cells, and IL-17AFrancesca Mancini, Elisabetta Monaci, Giuseppe Lofano, et al.
Journal of Clinical Medicine|July 12, 2025
ChatGPT in the Management of Chronic Rhinosinusitis with Nasal Polyps: Promising Support or Digital Illusion? Insights from a Multicenter Observational StudyRiccardo Manzella, Angelo Immordino, Cosimo Galletti, et al.
Infection and Immunity|November 16, 2011
RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodiesCarole Harfouche, Sara Filippini, Claudia Gianfaldoni, et al.
Journal of Medicinal Chemistry|December 30, 2003
Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agentsGiuseppe Campiani, Stefania Butini, Caterina Fattorusso, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2015
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureusFabio Bagnoli, Maria Rita Fontana, Elisabetta Soldaini, et al.
Pageof 8